Monash Advanced Particle Engineering Laboratory, Department of Chemical Engineering, Monash University, Clayton, VIC, 3800 Australia.
Drug Dev Ind Pharm. 2013 Sep;39(9):1389-400. doi: 10.3109/03639045.2012.719233. Epub 2012 Oct 12.
Foam granulation technology is a new wet granulation approach for pharmaceutical formulations. This study evaluates the performance of foam and spray granulation in achieving uniform drug distribution using a model formulation. To observe wetting and nuclei formation, single drop/foam penetration experiments were performed on a static powder bed comprised of varying compositions of hydrophilic/hydrophobic glass ballotini, and hydrophilic lactose/hydrophobic salicylic acid respectively. High shear granulation experiments were performed in a 5L mixer using varying compositions of hydrophilic lactose and hydrophobic salicylic acid. Four percent hydroxylpropyl methylcellulose (HPMC) solution was delivered at 90 g/min as either a foam (92% FQ) or an atomized spray whilst recording impeller power consumption. After drying, the granule size distribution was measured and the granule composition was estimated using gravimetric filtration in methanol. Foam penetration was less dependent on the powder hydrophobicity compared to drop penetration. For glass ballotini powder mixtures, foam induced nucleation created nuclei with relatively uniform structure and size regardless of the powder hydrophobicity. For salicylic acid and lactose mixtures, increasing the proportion of salicylic acid reduced the nuclei granule size for both foam and drop binder addition. The granule drug distribution was not significantly affected by the binder addition method. Processing conditions, including liquid binder amount, impeller speed, wet massing, and the wettability properties of the formulation were the dominant factors for delivering homogeneous granules. The study reveals that foam and spray granulation involve different nucleation mechanisms - spray tends to incur early liquid penetration whereas foam granulation operates well in mechanical dispersion.
泡沫造粒技术是一种新的药物制剂湿法制粒方法。本研究通过模型配方评估了泡沫和喷雾造粒在实现药物均匀分布方面的性能。为了观察润湿和核形成,在由不同比例亲水性/疏水性玻璃微珠和亲水性乳糖/疏水性水杨酸组成的静态粉末床上进行了单滴/泡沫渗透实验。在 5L 混合机中进行高剪切制粒实验,使用不同比例的亲水性乳糖和疏水性水杨酸。以 90g/min 的速度分别将 4%羟丙基甲基纤维素(HPMC)溶液作为泡沫(92%FQ)或雾化喷雾输送,同时记录搅拌器功率消耗。干燥后,测量颗粒大小分布,并使用甲醇中的重量过滤法估计颗粒组成。与液滴渗透相比,泡沫渗透对粉末疏水性的依赖性较小。对于玻璃微珠粉末混合物,泡沫诱导成核产生的核具有相对均匀的结构和大小,而与粉末疏水性无关。对于水杨酸和乳糖混合物,随着水杨酸比例的增加,泡沫和液滴添加结合剂都会减小核颗粒的大小。颗粒药物分布不受结合剂添加方法的显著影响。加工条件,包括液体结合剂用量、搅拌器速度、湿混和制剂的润湿性,是提供均匀颗粒的主要因素。该研究表明,泡沫和喷雾造粒涉及不同的成核机制——喷雾倾向于较早地发生液体渗透,而泡沫造粒在机械分散方面表现良好。